Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: Bone Marrow Transplant. 2010 Jun 28;46(4):510–515. doi: 10.1038/bmt.2010.160

Table 4.

Response to topotecan, melphalan and CY regimen

First
remission
Refractory/
relapsed
Total N (%)
sCR 1 1 2 (3.3)
CR 3 2 5 (8.3)
VGPR 19 7 26 (43.3)
Partial response 11 7 18 (30)
Stable disease 6 2 8 (13)
Progressive disease 1 0 1 (2)

Abbreviations: CR = complete response; sCR = stringent complete response; VGPR = very good partial response.